Altamura, Sandro

Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy

Cabezas-Wallscheid, N., Buettner, F., Sommerkamp, P., Klimmeck, D., Ladel, L., Thalheimer, F. B., Pastor-Flores, D., Roma, L. P., Renders, S., Zeisberger, P., et al. (2017) · Cell

Hematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processes

Cited by 454

Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 369

Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause

Scognamiglio, R., Cabezas-Wallscheid, N., Thier, M. C., Altamura, S., Reyes, A., Prendergast, Á. M., Baumgärtner, D., Carnevalli, L. S., Atzberger, A., Haas, S., et al. (2016) · Cell

Pluripotent Stem Cells ResearchDevelopmental Biology and Gene Regulation

Cited by 271

A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia

Guida, C., Altamura, S., Klein, F. A., Galy, B., Boutros, M., Ulmer, A. J., Hentze, M. W., & Muckenthaler, M. U. (2015) · Blood

Iron Metabolism and DisordersImmune Response and Inflammation

Cited by 173

Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD

Casanovas, G., Mleczko-Sanecka, K., Altamura, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Journal of Molecular Medicine

Iron Metabolism and DisordersTGF-β signaling in diseases

Cited by 161

Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload

Altamura, S., Kessler, R., Gröne, H.-J., Gretz, N., Hentze, M. W., Galy, B., & Muckenthaler, M. U. (2014) · Cell Metabolism

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 119

Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling

Rauner, M., Baschant, U., Roetto, A., Pellegrino, R. M., Rother, S., Salbach-Hirsch, J., Weidner, H., Hintze, V., Campbell, G., Petzold, A., et al. (2019) · Nature Metabolism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 87

Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome

Cozzi, A., Santambrogio, P., Privitera, D., Broccoli, V., Rotundo, L. I., Garavaglia, B., Benz, R., Altamura, S., Goede, J. S., Muckenthaler, M. U., et al. (2013) · Journal of Experimental Medicine

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 47

Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model

Artuso, I., Lidonnici, M. R., Altamura, S., Mandelli, G., Pettinato, M., Muckenthaler, M. U., Silvestri, L., Ferrari, G., Camaschella, C., & Nai, A. (2018) · Blood

Hemoglobinopathies and Related DisordersErythropoietin and Anemia Treatment

Cited by 38

Mice with hepcidin‐resistant ferroportin accumulate iron in the retina

Theurl, M., Song, D., Clark, E., Sterling, J., Grieco, S., Altamura, S., Galy, B., Hentze, M., Muckenthaler, M. U., & Dunaief, J. L. (2016) · The FASEB Journal

Iron Metabolism and DisordersRetinal Development and Disorders

Cited by 36

Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to dichotomous opposing phenotypes during MCD diet-induced NASH

Jansakun, C., Chunglok, W., Altamura, S., Muckenthaler, M., Staffer, S., Tuma-Kellner, S., Merle, U., & Chamulitrat, W. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 8